---  
layout: startup_page  
title: "Imvax"  
id: "imvax.com"  
permalink: "/imvaximvax.com01292025/"  
website: "https://www.imvax.com/"  
funding_round: ""  
funding_amount: "$29M"  
investors: "existing investors"  
about: "Imvax, Inc. is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies for solid tumors. Their most advanced program, IGV-001, is in a Phase 2b clinical trial for newly diagnosed glioblastoma. The company utilizes its proprietary GoldspireÂ® immuno-oncology platform to induce a broad and durable immune response against tumors."  
markets: "Biotechnology, Immunotherapy, Pharmaceutical, Therapeutics, Oncology"  
hq: "Philadelphia, Pennsylvania, United States"  
founded_year: "2015"  
linkedin: "https://www.linkedin.com/company/imvax-inc"  
twitter: "https://twitter.com/imvax_inc"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/imvax"  
pitchbook: "https://pitchbook.com/profiles/company/267714-64"  

date_display: "29-Jan-2025"  
date: "2025-01-29"

# SEO Optimization  
meta_title: "Imvax -  Funding ($29M)"  
meta_description: "Imvax, Imvax, Inc. is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies for solid tumors. Their most advanc..."  
meta_keywords: "Imvax, Biotechnology, Immunotherapy, Pharmaceutical, Therapeutics, Oncology,  funding"  
canonical_url: "https://startup.projectstartups.com/imvaximvax.com01292025/"  
---